Activated CD8+ T cells have been shown to kill breast cancer cells directly in vitro (10) and in an animal model in vivo (11); whereas infiltrating CD4+ cells contribute to the host immunity against malignant cells indirectly via secreting cytokines, e.g. IL-6, TNF, IL-18 (12). This evidence concerns the gene CD8A and breast carcinoma.